Last reviewed · How we verify
NCT04921202
Metabolic Syndrome and Degenerative Meniscus Lesions Related Knee Function
trial testing Metabolic syndrome and meniscus injuries in Metabolic Syndrome in 180 participants. Completed in 1 March 2021.
25 March 2020
Quick facts
| Lead sponsor | The First People's Hospital of Jingzhou |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 180 |
| Start date | 1 June 2017 |
| Primary completion | 25 March 2020 |
| Estimated completion | 1 March 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Metabolic syndrome and meniscus injuries
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Meniscus Lesion — all drugs for Meniscus Lesion →
- Obesity, Abdominal — all drugs for Obesity, Abdominal →
- Knee Arthritis — all drugs for Knee Arthritis →
Sponsor
The First People's Hospital of Jingzhou
Who can join
Adults 35 to 70, any sex, with Metabolic Syndrome or Meniscus Lesion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Studies have suggested that Obese patients with metabolic syndrome(MetS)were correlated with knee joint degeneration and osteoarthritis. However, no studies demonstrate the relationship between obese patients with metabolic syndrome and degenerate meniscus lesions and its knee function.The aim is to detect the correlation between obese patients with metabolic syndrome and degenerate meniscus injuries.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04921202
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other The First People's Hospital of Jingzhou trials
Trials by the same sponsor.
- NCT06868004 — Holistic Nursing Benefits Cognitive and Psychiatric Symptoms in Alzheimer's Patients · NA · completed
- NCT05092178 — Calorie Restricted Diet and Exercise · NA · completed
- NCT05114694 — Early Arthroscopic Partial Meniscectomy(APM) · NA · unknown
- NCT04837456 — Metabolic Syndrome and Degenerate Meniscus Tears · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04921202 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First People's Hospital of Jingzhou
- Last refreshed: 10 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04921202.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing